GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synthorx Inc (NAS:THOR) » Definitions » PensionAndRetirementBenefit

Synthorx (Synthorx) PensionAndRetirementBenefit : $0.00 Mil (As of Sep. 2019)


View and export this data going back to 2018. Start your Free Trial

What is Synthorx PensionAndRetirementBenefit?

Synthorx's PensionAndRetirementBenefit for the quarter that ended in Sep. 2019 was $0.00 Mil.


Synthorx PensionAndRetirementBenefit Historical Data

The historical data trend for Synthorx's PensionAndRetirementBenefit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synthorx PensionAndRetirementBenefit Chart

Synthorx Annual Data
Trend Dec16 Dec17 Dec18
PensionAndRetirementBenefit
- - -

Synthorx Quarterly Data
Dec16 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
PensionAndRetirementBenefit Get a 7-Day Free Trial Premium Member Only - - - - -

Synthorx PensionAndRetirementBenefit Calculation

PensionAndRetirementBenefit is the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement.


Synthorx (Synthorx) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
11099 North Torrey Pines Road, Suite 290, La Jolla, CA, USA, 92037
Executives
Powell Andrew Kenneth William director C/O COLLAGENEX PHARMACEUTICALS, INC., 41 UNIVERSITY DRIVE, NEWTOWN PA 18940
Ra Capital Healthcare Fund Lp 10 percent owner 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Ra Capital Management, L.p. 10 percent owner 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Peter Kolchinsky director, 10 percent owner 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Peter A. Thompson director, 10 percent owner C/O ANTHERA PHARMACEUTICALS, INC., 25801 INDUSTRIAL BOULEVARD, SUITE B, HAYWARD CA 94545
Vickie L Capps director 2985 SCOTT STREET, VISTA CA 92083
Rajeev M. Shah 10 percent owner 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Jay Lichter director C/O ARATANA THERAPEUTICS, INC., 11400 TOMAHAWK CREEK PARKWAY, SUITE 340, LEAWOOD KS 66211
Laura Shawver director, officer: President and CEO 1255 CRESCENT GREEN DRIVE, SUITE 250, CARY NC 27518
Avalon Ventures X, L.p. 10 percent owner 1134 KLINE STREET, LA JOLLA CA 92037
Orbimed Advisors Llc director, 10 percent owner 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
Orbimed Capital Gp Vii Llc 10 percent owner 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022

Synthorx (Synthorx) Headlines

From GuruFocus

Synthorx Announces Pricing of Initial Public Offering

By GlobeNewswire GlobeNewswire 12-07-2018

Synthorx to Present at Upcoming Investor Conferences

By Marketwired Marketwired 11-13-2019

Synthorx Announces Pricing of Initial Public Offering

By Marketwired Marketwired 12-07-2018

Synthorx Reports Third Quarter Financial Results

By Marketwired Marketwired 11-06-2019

Monday Morning Market Highlights

By Omar Venerio Omar Venerio 06-08-2020

Synthorx Reports Second Quarter Financial Results

By Marketwired Marketwired 08-02-2019